Recherche
Résultats 71-80 de 188
-
Dermatofibrosarcoma: management
Bulletin du cancer, 05-10-2018Article dans une revue scientifique -
Personalised management of alveolar soft part sarcoma: a promising phase 2 study
The Lancet. Oncology, 08-05-2019Article dans une revue scientifique -
Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
The Lancet. Oncology, 20-03-2018Article dans une revue scientifique -
Use of pd-1 targeting, macrophage infiltration, and ido pathway activation in sarcomas a phase 2 clinical trial
JAMA oncology, 01-01-2018, 4, 93-97Article dans une revue scientifique -
Activity and safety of palbociclib in patients with advanced gastrointestinal stromal tumors refractory to imatinib and sunitinib: a biomarker-driven phase 2 study
Clinical cancer research . an official journal of the American Association for Cancer Research, 12-04-2019Article dans une revue scientifique -
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (regosarc): a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet. Oncology, 01-12-2016, 17, 1732-1742Article dans une revue scientifique -
Surgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the french sarcoma group
European journal of cancer (Oxford, England . 1990), 01-09-2017, 83, 125-131Article dans une revue scientifique -
How to emerge from the conservatism in clinical research methodology?
Current opinion in oncology, 01-09-2017, 29, 400-404Article dans une revue scientifique -
Overview of � druggable � alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies
Critical Reviews in Oncology/Hematology, 14-04-2020, 150, 102960Article dans une revue scientifique -
Paclitaxel given once per week with or without bevacizumab in patients with advanced angiosarcoma: a randomized phase ii trial
Journal of clinical oncology . official journal of the American Society of Clinical Oncology, 01-09-2015, 33, 2797-U116Article dans une revue scientifique